How Well do Primary Care Doctors in Region Örebro County, Sweden Follow Diagnostic Guidelines of IBS?
NCT04859972 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2021-11-23
Summary
The aim of this project is to investigate the implementation of the Rome criteria in daily primary care clinical practice and adherence of general practitioners (GPs) to recommended diagnostic approaches for IBS.
Conditions
- Irritable Bowel Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Diagnosis of IBS
Diagnosis of IBS according to ICD-10
Sponsors & Collaborators
-
Region Örebro County
lead OTHER
Principal Investigators
-
Michiel van Nieuwenhoven, Associate Professor, M.D. PhD. · Region Örebro County
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-22
- Primary Completion
- 2022-08-31
- Completion
- 2023-05-31
More Related Trials
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Psychological and Dietary Treatment in IBS
NCT04770883 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome
NCT03986476 ·Status: COMPLETED ·Phase: NA
-
Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 ·Status: COMPLETED
-
Effect of Serotonergic Stimulation on the Gut-brain Axis
NCT03920410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Microbiota Profiling in IBS
NCT03720314 ·Status: COMPLETED
-
Effects of Faecal Microbiota Transplantation in Patients With IBS
NCT03822299 ·Status: COMPLETED ·Phase: NA
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903 ·Status: COMPLETED
-
The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
NCT05340400 ·Status: COMPLETED
-
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
NCT05721742 ·Status: RECRUITING ·Phase: NA
-
Mediterranean Diet and the Gut Microbiome
NCT03269032 ·Status: COMPLETED ·Phase: NA
-
Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)
NCT01912313 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
NCT00583128 ·Status: COMPLETED ·Phase: PHASE2
-
Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients
NCT02550704 ·Status: COMPLETED ·Phase: NA
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
Application of Chemical Sensors for Diagnosis of Inflammatory Bowel Diseases and Irritable Bowel Syndrome by Respiratory Samples
NCT01242163 ·Status: UNKNOWN
-
Comparing of the Gastrointestinal Motility in Irritable Bowel Syndrome (IBS) Patients With Healthy Volunteers
NCT00957398 ·Status: TERMINATED
-
Spatial Analysis of the Intestinal Microbiota in Healthy Subjects
NCT03918330 ·Status: COMPLETED
-
Rapid Orocecal Transit Time and Fermentation in IBS.
NCT03141268 ·Status: UNKNOWN
-
Diet and Motility in IBS
NCT07283341 ·Status: RECRUITING
-
Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
NCT04074421 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comorbid Esophageal Disorders in IBS Patients
NCT04759378 ·Status: UNKNOWN ·Phase: NA